Peers for comparison


Market capitalization
‪65.41 B‬ EURLarge cap
5.45 EUR
‪2.61 B‬ EUR
‪21.10 B‬ EUR
‪125.42 M‬
Beta (1Y)
1.26
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Employees (FY)
‪62.46 K‬
Change (1Y)
−96−0.15%
Revenue / Employee (1Y)
‪337.84 K‬ EUR
Net income / Employee (1Y)
‪41.75 K‬ EUR

Company info


CEO
Kai Beckmann
Headquarters
Darmstadt
IPO date
Oct 20, 1995
ISIN
DE0006599905
FIGI
BBG000BX4SN3
Identifiers
ISIN DE0006599905
CFI code
ESVUFB
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateJun 15, 2030
Coupon2.38% (Fixed)
Maturity dateJul 5, 2031
Coupon0.88% (Fixed)
Maturity dateJul 16, 2028
Coupon0.50% (Fixed)
Maturity dateJul 5, 2027
Coupon0.38% (Fixed)
Maturity dateAug 27, 2054
Coupon3.88% (Variable)
Maturity dateNov 24, 2055
Coupon3.75% (Variable)
Maturity dateJun 25, 2079
Coupon2.88% (Variable)

See all MRK bonds 

Weight0.05%
Market value‪297.06 M‬
Weight0.06%
Market value‪196.14 M‬
Weight0.09%
Market value‪163.54 M‬
Weight1.09%
Market value‪106.37 M‬
Weight1.09%
Market value‪106.37 M‬
Weight6.26%
Market value‪89.96 M‬
Weight6.26%
Market value‪89.96 M‬
Weight1.08%
Market value‪88.38 M‬
Weight1.08%
Market value‪88.38 M‬
Weight0.10%
Market value‪76.60 M‬

Explore more ETFs 

Frequently asked questions


Merck KGaA is scheduled to release its next earnings report on Nov 12, 2026.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
MRK stock is 1.61% volatile and has beta coefficient of 1.26.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like MRK are typically less volatile than smaller companies

Track every detail on Merck KGaA stock chart and check out the list of the most volatile stocks — is Merck KGaA there?
To understand the MRK stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −0.27%
– 1 week — −1.00%
– 1 month — +7.10%

MRK all-time low was 8.60 EUR (Sep 30, 2002), and its highest price is 231.30 EUR (Dec 29, 2021). Find more dynamics in the Stock Heatmap and on the Merck KGaA stock chart.
Merck KGaA market capitalization is ‪65.41 B‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Merck KGaA stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Merck KGaA stacks up against other companies
The safest way to buy Merck KGaA stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade MRK directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 7, 2026, the company has ‪62.46 K‬ employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Merck KGaA pays dividends, but whether it is a “good” dividend stock depends on its yield and stability rather than dividends alone.

Its recent dividend yield was around 1.79%, with a payout ratio of 36.68%, compared to 1.57% and 34.44% in the previous period.

What to look at when looking for good dividend stocks:
– Dividend yield: Income potential relative to price
– Payout ratio: Sustainability of dividend payments
– Dividend history: Consistency and growth over time
– Earnings strength: Dividends are more reliable when supported by stable profits
– Total return: Combines dividends with stock price performance

Explore all this in Merck KGaA financials.
Investing in Merck KGaA depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Merck KGaA financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our MRK technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — buy

Combine fundamental and technical analysis for better results.
Merck KGaA stock ticker depends on the exchange where it’s listed. On the XETR, its primary exchange, Merck KGaA stocks trade under the symbol MRK.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
MRK earnings for the last quarter are 2.16 EUR per share, whereas the estimation was 2.03 EUR, resulting in a 6.61% surprise. The estimated earnings for the next quarter are 2.18 EUR per share.

How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one

Follow other essential metrics in Merck KGaA financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
Merck KGaA revenue for the last quarter amounts to ‪5.43 B‬ EUR despite the estimated figure of ‪5.29 B‬ EUR. In the next quarter revenue is expected to reach ‪5.48 B‬ EUR.

How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance

Follow other essential metrics in Merck KGaA financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track Merck KGaA financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
MRK net income for the last quarter is ‪490.00 M‬ EUR, while the quarter before that showed ‪660.00 M‬ EUR of net income which accounts for −25.76% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in Merck KGaA financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
Merck KGaA does pay dividends, which are distributed annually. The most recent dividend per share was 2.20 EUR, with a trailing twelve-month (TTM) dividend yield of 1.46%.

Explore more details on Merck KGaA dividends, look at:
– Dividend history: Check whether payouts are growing, stable, or declining
– Payout ratio: How much of earnings are paid out as dividends
– Total return: Combine price growth + dividends for full performance view
MRK reached its all-time high of 231.30 EUR on Dec 29, 2021. Its all-time low was 8.60 EUR and was reached on Sep 30, 2002.

Explore the Merck KGaA stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Merck KGaA EBITDA is ‪6.59 B‬ EUR, with an EBITDA margin of 28.17%.

EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.

What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures

What to look at next in Merck KGaA statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 135.00 EUR and 179.00 EUR for MRK, based on current estimates.

Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions

Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance